Myomar Molecular
2021
We are raising our seed round and would like more opportunities to showcase our technology to potential investors and partners.
Recent Posts
- Agilent Technologies to Acquire BIOVECTRA Inc., Creating New Synergistic Opportunities to Improve Patient Care
- Nova Scotia Health and Life Sciences Nova Scotia Enter Formal Collaboration
- Life Sciences Nova Scotia Shares Leadership Transition News
- NovaResp Technologies Inc. Raises $3.0M Seed Extension To Support Clinical Testing of its cMAP™ Positive Airway Pressure Software
- BioPort Atlantic 2024 Conference: Celebrating Atlantic Canada’s Life Sciences Innovations
